These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 16224495

  • 21. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K, Lee JB, Maitani Y, Toyooka N, Nemoto H, Hayashi T.
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [Abstract] [Full Text] [Related]

  • 22. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E, Kawano K, Hattori Y, Fukushima M, Hayashi K, Maitani Y.
    J Control Release; 2007 Jul 16; 120(1-2):104-10. PubMed ID: 17509714
    [Abstract] [Full Text] [Related]

  • 23. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC.
    Gene Ther; 2000 Sep 16; 7(17):1483-90. PubMed ID: 11001368
    [Abstract] [Full Text] [Related]

  • 24. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
    Cascante A, Abate-Daga D, Garcia-Rodríguez L, González JR, Alemany R, Fillat C.
    Gene Ther; 2007 Oct 16; 14(20):1471-80. PubMed ID: 17713568
    [Abstract] [Full Text] [Related]

  • 25. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y, Zhang X, Hui H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun 16; 7(2):113-5. PubMed ID: 10488424
    [Abstract] [Full Text] [Related]

  • 26. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
    Lifang Y, Min T, Midan A, Ya C.
    J Exp Clin Cancer Res; 2008 Sep 23; 27(1):42. PubMed ID: 18811956
    [Abstract] [Full Text] [Related]

  • 27. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.
    Hall SJ, Mutchnik SE, Yang G, Timme TL, Nasu Y, Bangma CH, Woo SL, Shaker M, Thompson TC.
    Cancer Gene Ther; 1999 Sep 23; 6(1):54-63. PubMed ID: 10078964
    [Abstract] [Full Text] [Related]

  • 28. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
    Mizuno M, Ryuke Y, Yoshida J.
    Cancer Gene Ther; 2002 Oct 23; 9(10):825-9. PubMed ID: 12224023
    [Abstract] [Full Text] [Related]

  • 29. Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy.
    Ketola A, Määttä AM, Pasanen T, Tulimäki K, Wahlfors J.
    Int J Mol Med; 2004 May 23; 13(5):705-10. PubMed ID: 15067374
    [Abstract] [Full Text] [Related]

  • 30. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S, Shimura S, Nasu Y, Kaku H, Kumon H, Yang G, Wang J, Timme TL, Aguilar-Cordova E, Thompson TC.
    Prostate Cancer Prostatic Dis; 2002 May 23; 5(4):316-25. PubMed ID: 12627218
    [Abstract] [Full Text] [Related]

  • 31. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
    Hall SJ, Sanford MA, Atkinson G, Chen SH.
    Cancer Res; 1998 Aug 01; 58(15):3221-5. PubMed ID: 9699645
    [Abstract] [Full Text] [Related]

  • 32. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM, Tenhunen A, Pasanen T, Meriläinen O, Pellinen R, Mäkinen K, Alhava E, Wahlfors J.
    Int J Oncol; 2004 Apr 01; 24(4):943-9. PubMed ID: 15010834
    [Abstract] [Full Text] [Related]

  • 33. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
    Kurdow R, Schniewind B, Boehle AS, Haye S, Boenicke L, Dohrmann P, Kalthoff H.
    Anticancer Res; 2004 Apr 01; 24(2B):827-31. PubMed ID: 15161034
    [Abstract] [Full Text] [Related]

  • 34. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
    Isomoto H, Ohtsuru A, Braiden V, Iwamatsu M, Miki F, Kawashita Y, Mizuta Y, Kaneda Y, Kohno S, Yamashita S.
    Oncol Rep; 2006 Mar 01; 15(3):629-35. PubMed ID: 16465423
    [Abstract] [Full Text] [Related]

  • 35. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
    Su H, Lu R, Ding R, Kan YW.
    Mol Ther; 2000 Jun 01; 1(6):509-15. PubMed ID: 10933975
    [Abstract] [Full Text] [Related]

  • 36. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
    Kojima Y, Honda K, Hamada H, Kobayashi N.
    J Surg Res; 2009 Nov 01; 157(1):e63-70. PubMed ID: 19345377
    [Abstract] [Full Text] [Related]

  • 37. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A, Moriuchi S, Lunsford LD, Kondziolka D, Flickinger JC, Fellows W, Rajendiran S, Tamura M, Cohen JB, Glorioso JC.
    Mol Ther; 2000 Aug 01; 2(2):114-20. PubMed ID: 10947938
    [Abstract] [Full Text] [Related]

  • 38. [Tegument viral protein 22 enhanced cell-killing effect of the herpes simplex virus thymidine kinase/ganciclovir system on ovarian cancer in vivo].
    Kong BH, Wang WX, Liu CS, Ma DX, Qu X.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr 01; 38(4):195-8. PubMed ID: 12885362
    [Abstract] [Full Text] [Related]

  • 39. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
    Yang J, Liu TJ, Lu Y.
    Curr Eye Res; 2007 Jan 01; 32(1):33-42. PubMed ID: 17364733
    [Abstract] [Full Text] [Related]

  • 40. [Recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene transfer followed by ganiciclovir administration effectively inhibits growth of human small-cell lung cancer in a murine xenotransplant model].
    Zhou JF, Chen G, Lu YP, Wang SX, Ma D.
    Zhonghua Zhong Liu Za Zhi; 2004 Feb 01; 26(2):68-70. PubMed ID: 15059319
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.